







IMPORTANT!
THE PRICE OF THE TEST INCLUDES A DNA SAMPLE COLLECTION KIT.
The Apixmed Prism Glucose and Metabolic Syndrome genetic test covers 51 markers across nine areas of carbohydrate and energy metabolism, including 36 complex markers and 15 individual genetic variants in 15 genes.
A DNA kit for collecting your saliva sample yourself is already included in the price of the test.
Genotyping of the sample in an accredited laboratory.
A report explaining 51 markers and genetic variants in plain language, with an interpretation of the results:
36 polygenic (complex) traits with an explanation of your individual result and what it means;
15 individual genetic variants with an explanation of their possible biological significance.
Context for every marker: genetics is not considered in isolation from lifestyle, age, environment and other factors.
Personalized recommendations on nutrition, physical activity, sleep, lifestyle and preventive approaches.
The option of a consultation with an Apixmed Prism specialist based on your report results.
Pointers to potentially relevant laboratory or clinical parameters that you can discuss with your doctor.
Data protection in line with ISO 27001, GDPR and HIPAA standards.
The Glucose and Metabolic Syndrome genetic test covers nine areas, within which it analyzes 36 complex markers and 15 individual genetic variants in 15 genes: from glycemic biomarkers and insulin action to body composition, appetite regulation and metabolic conditions. It assesses how your genetic profile and individual genetic variants are associated with a relatively higher or lower predisposition for each marker compared with a reference population. The test does not measure blood glucose or insulin levels — instead it examines the stable genetic context that complements laboratory tests rather than replacing them.
DNA sample collection is done using saliva. You receive the kit by post and collect your own DNA sample into a special tube — it takes just a few minutes and requires no preparation. The sample is then sent for analysis to an accredited laboratory, and you receive your result in digital format.
36 markers across nine areas. Assessed using polygenic risk scores: tens and hundreds of variants together shape the contribution to a predisposition, and no single one of them determines the picture on its own.
Glycemic biomarkers: fasting glucose, glycated hemoglobin, glucagon
Insulin secretion and action: insulin, proinsulin, HOMA-B (beta-cell function), insulin sensitivity
Spectrum of carbohydrate metabolism disorders: prediabetes, type 1 diabetes, type 2 diabetes
Overall fat mass: body mass index (BMI), body fat percentage, overweight, obesity
Body composition (fat and muscle mass): waist circumference, hip circumference, visceral fat, liver fat fraction, appendicular lean mass, body-to-muscle mass ratio
Adipokines: adiponectin, leptin, resistin
Appetite regulation signals: appetite-regulating hormones, ghrelin, the leptin receptor, soluble leptin receptor, peptide YY, agouti-related peptide
Metabolic conditions and urate: metabolic syndrome, metabolic dysfunction-associated steatotic liver disease (MASLD, also known as fatty liver disease), uric acid, gout
Diabetic complications: diabetic neuropathy, diabetic nephropathy, diabetic retinopathy
15 genetic variants in 15 genes. A mechanistic link to the trait is described for each, so they are interpreted individually and are not included in the complex markers.
SLC30A8, PPARG and KCNJ11: associated with type 2 diabetes
MTNR1B: the melatonin receptor, associated with glucose levels
TCF7L2: a variant of this gene is one of the most reproducible associations with type 2 diabetes
GCKR: regulation of glucose and lipid metabolism in the liver
ADRB3 and PLIN1: associated with lipolysis (the breakdown of fat tissue)
UCP1 and UCP2: associated with thermogenesis and energy metabolism
FTO: regulation of appetite and body weight, associated with body mass index
MC4R: associated with appetite regulation and BMI
PNPLA3 and TM6SF2: associated with liver fat accumulation
ABCG2: associated with uric acid levels
Family history of type 2 diabetes or obesity: specific genetic context for a conversation with an endocrinologist, not a reason for conclusions on your own.
Interest in weight management: additional context on energy metabolism and appetite alongside professional nutritional assessment.
Existing risk factors for metabolic syndrome: specific topics for laboratory monitoring instead of guesswork.
When choosing supplements: a reason to discuss whether they are appropriate with your doctor, not grounds to change anything on your own.
The Glucose and Metabolic Syndrome test is not a diagnosis and does not replace consultation with a doctor.
The results assess probability rather than establishing a predetermined outcome. They are not a diagnosis, do not confirm a disease and do not determine treatment. The test does not replace glucose, glycated hemoglobin or other laboratory measurements. Clinical decisions are made by a specialist, taking into account your history, symptoms, diet, age, medication and laboratory data.